Gene mutations are closely associated with tumors and are often associated with poor tumor prognosis, but the proportion of PCK2 gene changes in HCC is too low, and gene changes are not significantly associated with poor OS, and are statistically significant with disease-free survival. The gene discussed is PCK2; the disease is hepatocellular carcinoma.